Reproductive endocrinology

Effect of Hormone Therapy on Lipoprotein Subfractions in Early and Late Postmenopausal Women

J Clin Endocrinol MetabPublished Secondary analysis of the ELITE randomised controlled trial

Authors' conclusion

HT effects on standard lipids and LPs are consistent with the literature. HT has similar effect on lipids and LPs in early and late PMW. Novel findings include discordant effects of HT on TG and VLDL particles, which can be explained by increased catabolism of atherogenic remnants of TG-rich lipoproteins. Our findings extend the well-known HT effects on standard lipids and LPs that may contribute to the beneficial effects on atherosclerosis progression in PMW.

Study context

Population
Healthy postmenopausal women (PMW), early and late postmenopausal; academic institution240 early, 322 late
Participants
562 participants
Comparison
Oral E2 with/without sequential vaginal progesterone (hormone therapy (HT)) vs control, by time-since-menopause
Primary endpoint
Standard lipids and 21 LPs quantitated by ion mobility
Follow-up
Every 6 months
Methodological detailsstratified by time-since-menopause
  • Stratified by time-since-menopause

Primary result

As reported in the abstract

  • HT significantly increased total triglycerides (TG), high-density lipoprotein (HDL) cholesterol, small low-density lipoproteins (LDL), large HDL, and TG/C ratio in LDL and HDL
  • HT decreased LDL-C, total very low density lipoproteins (VLDL), small VLDL, intermediate-density lipoproteins, large LDL, and LDL peak diameter
  • No lipid or LP differences between time-since-menopause strata

Further findings

E2 level and lipids/LPs

Associations of E2 level with lipids and LPs explained the HT effects

Lipids/LPs and atherosclerosis progression

Very small LDL and total HDL LPs associated with atherosclerosis progression in late PMW
  • Nonsignificant P interaction by time-since-menopause

Original publication

Effect of Hormone Therapy on Lipoprotein Subfractions in Early and Late Postmenopausal Women. J Clin Endocrinol Metab. Published 28 March 2024. doi:10.1210/clinem/dgae171

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.